FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

926312002: Pralsetinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4042885019 Pralsetinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042886018 Pralsetinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042885019 Pralsetinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042886018 Pralsetinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pralsetinib (substance) Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Pralsetinib (substance) Is a Pyridine true Inferred relationship Existential restriction modifier (core metadata concept)
Pralsetinib (substance) Has disposition Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Pralsetinib (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Pralsetinib (substance) Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Pralsetinib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pralsetinib (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing pralsetinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pralsetinib (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Pralsetinib-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pralsetinib (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Pralsetinib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pralsetinib (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Pralsetinib 100 mg oral capsule Has precise active ingredient True Pralsetinib (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Pralsetinib 100 mg oral capsule Has basis of strength substance (attribute) True Pralsetinib (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start